These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 16087809)

  • 1. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy.
    Rickers C; Wilke NM; Jerosch-Herold M; Casey SA; Panse P; Panse N; Weil J; Zenovich AG; Maron BJ
    Circulation; 2005 Aug; 112(6):855-61. PubMed ID: 16087809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance.
    Maron MS; Maron BJ; Harrigan C; Buros J; Gibson CM; Olivotto I; Biller L; Lesser JR; Udelson JE; Manning WJ; Appelbaum E
    J Am Coll Cardiol; 2009 Jul; 54(3):220-8. PubMed ID: 19589434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the left ventricular anatomy in hypertrophic cardiomyopathy: comparison between echocardiography and cardiac magnetic resonance imaging.
    Romano R; Losi MA; Migliore T; Contaldi C; Parrella LS; Caputi A; Betocchi S
    Minerva Cardioangiol; 2008 Apr; 56(2):181-7. PubMed ID: 18319696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations.
    Germans T; Wilde AA; Dijkmans PA; Chai W; Kamp O; Pinto YM; van Rossum AC
    J Am Coll Cardiol; 2006 Dec; 48(12):2518-23. PubMed ID: 17174192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular wall thickness in patients with hypertrophic cardiomyopathy: a comparison between cardiac magnetic resonance imaging and echocardiography.
    Corona-Villalobos CP; Sorensen LL; Pozios I; Chu L; Eng J; Abraham MR; Abraham TP; Kamel IR; Zimmerman SL
    Int J Cardiovasc Imaging; 2016 Jun; 32(6):945-54. PubMed ID: 26896038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy.
    Maron MS
    J Cardiovasc Transl Res; 2009 Dec; 2(4):415-25. PubMed ID: 20560000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early changes in apical rotation in genotype positive children with hypertrophic cardiomyopathy mutations without hypertrophic changes on two-dimensional imaging.
    Forsey J; Benson L; Rozenblyum E; Friedberg MK; Mertens L
    J Am Soc Echocardiogr; 2014 Feb; 27(2):215-21. PubMed ID: 24325958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spirito-Maron echocardiographic score: a marker for morphological and physiological assessment of patients with hypertrophic cardiomyopathy.
    Rangel I; Gonçalves A; de Sousa C; Correia AS; Pinho T; Madureira AJ; Martins E; Cardoso JS; Macedo F; Maciel MJ
    Echocardiography; 2014 Jul; 31(6):708-15. PubMed ID: 24460546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial Dimensions in Children With Hypertrophic Cardiomyopathy: A Comparison Between Echocardiography and Cardiac Magnetic Resonance Imaging.
    Windram JD; Dragelescu A; Benson L; Forsey J; Shariat M; Yoo SJ; Mertens L; Wong D; Grosse-Wortmann L
    Can J Cardiol; 2016 Dec; 32(12):1507-1512. PubMed ID: 27789109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
    Maron MS
    J Cardiovasc Magn Reson; 2012 Feb; 14(1):13. PubMed ID: 22296938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of Cardiac Magnetic Resonance Imaging to Measure Left Ventricular Wall Thickness for Determining Risk Scores for Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy.
    Webb J; Villa A; Bekri I; Shome J; Teall T; Claridge S; Jackson T; Porter B; Ismail TF; Di Giovine G; Rinaldi CA; Carr-White G; Al-Fakih K; Razavi R; Chiribiri A
    Am J Cardiol; 2017 May; 119(9):1450-1455. PubMed ID: 28267963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinguishing left ventricular hypertrophy from hypertrophic cardiomyopathy in adolescents: a longitudinal observation study.
    Forså MI; Smedsrud MK; Haugaa KH; Bjerring AW; Früh A; Sarvari SI; Landgraff HW; Hallén J; Edvardsen T
    Eur J Prev Cardiol; 2024 Mar; 31(5):591-598. PubMed ID: 37992187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hypertrophy and fibrosis on regional and global functional heterogeneity in hypertrophic cardiomyopathy.
    Chang SA; Lee SC; Choe YH; Hahn HJ; Jang SY; Park SJ; Choi JO; Park SW; Oh JK
    Int J Cardiovasc Imaging; 2012 Dec; 28 Suppl 2():133-40. PubMed ID: 23097128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy].
    Maron MS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Dec; 37(12):1057-63. PubMed ID: 20193172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Maximal Wall Thickness in Hypertrophic Cardiomyopathy Differs Between Magnetic Resonance Imaging and Transthoracic Echocardiography.
    Bois JP; Geske JB; Foley TA; Ommen SR; Pellikka PA
    Am J Cardiol; 2017 Feb; 119(4):643-650. PubMed ID: 27956002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrepant Measurements of Maximal Left Ventricular Wall Thickness Between Cardiac Magnetic Resonance Imaging and Echocardiography in Patients With Hypertrophic Cardiomyopathy.
    Hindieh W; Weissler-Snir A; Hammer H; Adler A; Rakowski H; Chan RH
    Circ Cardiovasc Imaging; 2017 Aug; 10(8):. PubMed ID: 28794137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementary Role of Echocardiography and Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy.
    Hindieh W; Chan R; Rakowski H
    Curr Cardiol Rep; 2017 Sep; 19(9):81. PubMed ID: 28752280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unravelling the grey zone: cardiac MRI volume to wall mass ratio to differentiate hypertrophic cardiomyopathy and the athlete's heart.
    Luijkx T; Cramer MJ; Buckens CF; Zaidi A; Rienks R; Mosterd A; Prakken NH; Dijkman B; Mali WP; Velthuis BK
    Br J Sports Med; 2015 Nov; 49(21):1404-9. PubMed ID: 23770661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
    Olivotto I; Maron MS; Autore C; Lesser JR; Rega L; Casolo G; De Santis M; Quarta G; Nistri S; Cecchi F; Salton CJ; Udelson JE; Manning WJ; Maron BJ
    J Am Coll Cardiol; 2008 Aug; 52(7):559-66. PubMed ID: 18687251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural history of left ventricular wall thickening in hypertrophic cardiomyopathy.
    Semsarian C; French J; Trent RJ; Richmond DR; Jeremy RW
    Aust N Z J Med; 1997 Feb; 27(1):51-8. PubMed ID: 9079254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.